This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Epoxide hydrolase
From Proteopedia
(Difference between revisions)
| Line 14: | Line 14: | ||
<scene name='70/708145/Cv/7'>Inhibitor binding site</scene> (PDB code [[5alf]]).<ref>PMID:25931264</ref> | <scene name='70/708145/Cv/7'>Inhibitor binding site</scene> (PDB code [[5alf]]).<ref>PMID:25931264</ref> | ||
| + | |||
| + | == 3D Structures of epoxide hydrolase== | ||
| + | [[Epoxide hydrolase 3D structures]] | ||
| + | |||
</StructureSection> | </StructureSection> | ||
| Line 27: | Line 31: | ||
**[[2cjp]] – pEH I – potato<br /> | **[[2cjp]] – pEH I – potato<br /> | ||
**[[3cxu]], [[4ufn]], [[4ufo]], [[4ufp]], [[4uhb]], [[4y9s]] – pEH (mutant) <br /> | **[[3cxu]], [[4ufn]], [[4ufo]], [[4ufp]], [[4uhb]], [[4y9s]] – pEH (mutant) <br /> | ||
| - | **[[4i19]], [[4qa9]], [[ | + | **[[4i19]], [[4qa9]], [[5f4z]] – EH – ''Streptomyces carzinostaticus''<br /> |
| + | **[[4qla]] – EH – silkworm<br /> | ||
| + | **[[5cxo]] – EH – ''Streptomyces albus''<br /> | ||
| + | **[[5nfq]], [[5ng7]] – EH – metagenome<br /> | ||
| + | **[[5xmd]] – mbEH – mung bean<br /> | ||
| + | **[[5y6y]], [[5y5d]], [[5xm6]] – mbEH (mutant)<br /> | ||
*Soluble epoxide hydrolase | *Soluble epoxide hydrolase | ||
**[[1s8o]], [[3i1y]], [[3i28]], [[3koo]], [[5ahx]], [[5fp0]] – hSEH – human<br /> | **[[1s8o]], [[3i1y]], [[3i28]], [[3koo]], [[5ahx]], [[5fp0]] – hSEH – human<br /> | ||
| + | **[[6i5e]] – hSEH C terminal<br /> | ||
**[[1cqz]] – mSEH – mouse<br /> | **[[1cqz]] – mSEH – mouse<br /> | ||
**[[4nzz]] – BmSEH – ''Bacillus megaterium''<br /> | **[[4nzz]] – BmSEH – ''Bacillus megaterium''<br /> | ||
| Line 42: | Line 52: | ||
**[[3rga]] – SlEH + oxazolidinone inhibitor – ''Streptomyces lasaliensis''<br /> | **[[3rga]] – SlEH + oxazolidinone inhibitor – ''Streptomyces lasaliensis''<br /> | ||
**[[4rzm]] – SlEH + lasalocid A<br /> | **[[4rzm]] – SlEH + lasalocid A<br /> | ||
| + | **[[5yb5]] – mbEH (mutant) + styrene derivative<br /> | ||
*Soluble epoxide hydrolase complex with inhibitor | *Soluble epoxide hydrolase complex with inhibitor | ||
| - | **[[1vj5]], [[1zd2]], [[1zd3]], [[1zd4]], [[1zd5]], [[3wk4]], [[4c4x]], [[4c4y]], [[4c4z]], [[5ai5]], [[5akz]], [[5ali]] – hSEH + urea derivative inhibitor<br /> | + | **[[1vj5]], [[1zd2]], [[1zd3]], [[1zd4]], [[1zd5]], [[3wk4]], [[4c4x]], [[4c4y]], [[4c4z]], [[5ai5]], [[5akz]], [[5ali]], [[6aum]], [[6fr2]] – hSEH + urea derivative inhibitor<br /> |
**[[1cr6]], [[1ek1]], [[1ek2]] – mSEH + urea derivative inhibitor<br /> | **[[1cr6]], [[1ek1]], [[1ek2]] – mSEH + urea derivative inhibitor<br /> | ||
**[[3otq]], [[3wk7]], [[4y2j]], [[4y2s]], [[4y2v]], [[5ak4]], [[5akh]], [[5aki]], [[5alk]], [[5alq]], [[5alv]], [[5aly]] – hSEH + pyrazole inhibitor<br /> | **[[3otq]], [[3wk7]], [[4y2j]], [[4y2s]], [[4y2v]], [[5ak4]], [[5akh]], [[5aki]], [[5alk]], [[5alq]], [[5alv]], [[5aly]] – hSEH + pyrazole inhibitor<br /> | ||
| Line 70: | Line 81: | ||
**[[5ai0]] – hSEH + phenyl oxadiazolamine inhibitor<br /> | **[[5ai0]] – hSEH + phenyl oxadiazolamine inhibitor<br /> | ||
**[[5ai9]] – hSEH + phenol derivative inhibitor<br /> | **[[5ai9]] – hSEH + phenol derivative inhibitor<br /> | ||
| - | **[[5aia]] – hSEH + benzoate derivative inhibitor<br /> | + | **[[5aia]], [[5mwa]] – hSEH + benzoate derivative inhibitor<br /> |
**[[5ak3]] – hSEH + indan-amine derivative inhibitor<br /> | **[[5ak3]] – hSEH + indan-amine derivative inhibitor<br /> | ||
**[[5all]] – hSEH + cyclohexyl methanol inhibitor<br /> | **[[5all]] – hSEH + cyclohexyl methanol inhibitor<br /> | ||
| + | **[[6i5g]] – hSEH C terminal + prostaglandin derivative<br /> | ||
**[[4o08]] – BmSEH + phenoxy acetamide inhibitor<br /> | **[[4o08]] – BmSEH + phenoxy acetamide inhibitor<br /> | ||
| Line 82: | Line 94: | ||
**[[1nww]] – ReEH – ''Rhodococcus erythropolis''<br /> | **[[1nww]] – ReEH – ''Rhodococcus erythropolis''<br /> | ||
| - | **[[4r9k]], [[4r9l]], [[4xbx]], [[4xdw]], [[5cf1]], [[5cf2]], [[5jpp]] – ReEH (mutant)<br /> | + | **[[4r9k]], [[4r9l]], [[4xbx]], [[4xdw]], [[5cf1]], [[5cf2]], [[5jpp]], [[5gkw]] – ReEH (mutant)<br /> |
**[[1nu3]] – ReEH + valpromide <br /> | **[[1nu3]] – ReEH + valpromide <br /> | ||
| - | **[[4xbt]], [[4xdv]], [[5clk]], [[5jpu]] – ReEH (mutant) + | + | **[[4xbt]], [[4xdv]], [[5clk]], [[5jpu]], [[5yao]] – ReEH (mutant) + hexane derivative<br /> |
| - | **[[4xby]], [[5ck6]] – ReEH (mutant) + cyclopentene oxide<br /> | + | **[[4xby]], [[5ck6]], [[5yng]], [[5yqt]] – ReEH (mutant) + cyclopentene oxide<br /> |
**[[5aif]], [[5aih]], [[5aii]] – mlEH – metagenomic library<br /> | **[[5aif]], [[5aih]], [[5aii]] – mlEH – metagenomic library<br /> | ||
**[[5aig]] – mlEH + valpromide <br /> | **[[5aig]] – mlEH + valpromide <br /> | ||
Revision as of 09:10, 23 June 2019
| |||||||||||
3D Structures of epoxide hydrolase
Updated on 23-June-2019
References
- ↑ Biswal BK, Morisseau C, Garen G, Cherney MM, Garen C, Niu C, Hammock BD, James MN. The molecular structure of epoxide hydrolase B from Mycobacterium tuberculosis and its complex with a urea-based inhibitor. J Mol Biol. 2008 Sep 12;381(4):897-912. Epub 2008 Jun 17. PMID:18585390 doi:10.1016/j.jmb.2008.06.030
- ↑ Arand M, Hallberg BM, Zou J, Bergfors T, Oesch F, van der Werf MJ, de Bont JA, Jones TA, Mowbray SL. Structure of Rhodococcus erythropolis limonene-1,2-epoxide hydrolase reveals a novel active site. EMBO J. 2003 Jun 2;22(11):2583-92. PMID:12773375 doi:http://dx.doi.org/10.1093/emboj/cdg275
- ↑ Imig JD, Hammock BD. Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases. Nat Rev Drug Discov. 2009 Oct;8(10):794-805. doi: 10.1038/nrd2875. PMID:19794443 doi:http://dx.doi.org/10.1038/nrd2875
- ↑ Oster L, Tapani S, Xue Y, Kack H. Successful generation of structural information for fragment-based drug discovery. Drug Discov Today. 2015 Apr 28. pii: S1359-6446(15)00154-3. doi:, 10.1016/j.drudis.2015.04.005. PMID:25931264 doi:http://dx.doi.org/10.1016/j.drudis.2015.04.005
